AU2003227952A8 - Metalloproteinase inhibitors - Google Patents

Metalloproteinase inhibitors

Info

Publication number
AU2003227952A8
AU2003227952A8 AU2003227952A AU2003227952A AU2003227952A8 AU 2003227952 A8 AU2003227952 A8 AU 2003227952A8 AU 2003227952 A AU2003227952 A AU 2003227952A AU 2003227952 A AU2003227952 A AU 2003227952A AU 2003227952 A8 AU2003227952 A8 AU 2003227952A8
Authority
AU
Australia
Prior art keywords
metalloproteinase inhibitors
metalloproteinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227952A
Other versions
AU2003227952A1 (en
Inventor
Andrew Paul Ayscough
Stephen John Davies
Gilles Pain
Jean-Yves Gillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Vernalis R&D Ltd
Original Assignee
Laboratoires Serono SA
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono SA, British Biotech Pharmaceuticals Ltd filed Critical Laboratoires Serono SA
Publication of AU2003227952A1 publication Critical patent/AU2003227952A1/en
Publication of AU2003227952A8 publication Critical patent/AU2003227952A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003227952A 2003-05-17 2003-05-17 Metalloproteinase inhibitors Abandoned AU2003227952A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2003/002138 WO2004101537A1 (en) 2003-05-17 2003-05-17 Metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
AU2003227952A1 AU2003227952A1 (en) 2004-12-03
AU2003227952A8 true AU2003227952A8 (en) 2004-12-03

Family

ID=33443479

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227952A Abandoned AU2003227952A1 (en) 2003-05-17 2003-05-17 Metalloproteinase inhibitors

Country Status (2)

Country Link
AU (1) AU2003227952A1 (en)
WO (1) WO2004101537A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153166B2 (en) * 2006-06-08 2012-04-10 Chih-Hsiung Lin Composition for prophylaxis or treatment of urinary system infection and method thereof
CN101353320A (en) * 2007-07-24 2009-01-28 中国人民解放军军事医学科学院毒物药物研究所 Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021625A1 (en) * 1993-03-16 1994-09-29 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as metalloproteinase inhibitors
GB9404046D0 (en) * 1994-03-03 1994-04-20 Smithkline Beecham Corp Novel compounds
US5703092A (en) * 1995-04-18 1997-12-30 The Dupont Merck Pharmaceutical Company Hydroxamic acid compounds as metalloprotease and TNF inhibitors
JP2002503649A (en) * 1998-02-13 2002-02-05 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド Cell growth inhibitor
JP2002506873A (en) * 1998-03-18 2002-03-05 アリアド・ファーマシューティカルズ・インコーポレイテッド Heterocyclic signaling inhibitors and compositions containing them
GB0204159D0 (en) * 2002-02-22 2002-04-10 British Biotech Pharm Metalloproteinase inhibitors

Also Published As

Publication number Publication date
AU2003227952A1 (en) 2004-12-03
WO2004101537A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
IL157656A0 (en) Metalloproteinase inhibitors
IL157570A0 (en) Metalloproteinase inhibitors
EP1663281A4 (en) Poly-pegylated protease inhibitors
IL157650A0 (en) Metalloproteinase inhibitors
SI2594265T1 (en) Ca ix-specific inhibitors
EP1499336A4 (en) Protease inhibitors
EP1532133A4 (en) Nf-:b inhibitors
AU2003249477A1 (en) Heterobicylcic metalloproteinase inhibitors
EP1663279A4 (en) Modified protease inhibitors
EP1613311A4 (en) Hif-1 inhibitors
EP1704142A4 (en) Protease inhibitors
EP1531857A4 (en) Metalloproteinase inhibitors
AU2003269984A8 (en) Protease inhibitors
AU2003263738A8 (en) Protease inhibitors
AU2003227952A8 (en) Metalloproteinase inhibitors
GB0319917D0 (en) Metalloproteinase inhibitors
GB0328632D0 (en) Metalloproteinase inhibitors
AU2003304496A8 (en) Protease inhibitors
AU2003233642A8 (en) Protease inhibitors
GB0329869D0 (en) Inhibitors
GB0300607D0 (en) Inhibitors
GB0312619D0 (en) Complement inhibitors
AU2003269878A8 (en) Protease inhibitors
AU2003265240A8 (en) Protease inhibitors

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 19, NO 2, PAGE(S) 101 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME BRITISHBIOTECH PHARMACEUTICALS LTD, APPLICATION NO. 2003227952, UNDER INID (71) CORRECT THE NAME TO READ BRITISH BIOTECH PHARMACEUTICALS LTD; LABORATOIRES SERONO S.A.

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase